Issued Patents All Time
Showing 1–13 of 13 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12240790 | Radiolabeling of polypeptides | Vadim Dudkin, Joseph Erhardt, Rhys Salter, Theresa McDevitt | 2025-03-04 |
| 12227593 | Site-specific conjugation of glycosylated monoclonal antibodies with transglutaminase | Vadim Dudkin, Michael J. McCauley, Kristen Wiley, Rebecca Wissner | 2025-02-18 |
| 12084475 | Methods for site specific conjugation of proteins containing glycosylated Fc domains | Vadim Dudkin, Michael J. McCauley, Kristen Wiley | 2024-09-10 |
| 12054534 | Prostate specific membrane antigen binding fibronectin type iii domains | Rosa Cardoso, Michael Diem, Linus Hyun, Steven Jacobs, Donna Klein +2 more | 2024-08-06 |
| 11987641 | Anti-PSMA antibodies and uses thereof | Donna Klein, Neeraj Kohli, Theresa McDevitt, Steven J. Orcutt | 2024-05-21 |
| 11702475 | Cysteine engineered fibronectin type III domain binding molecules | Steven Jacobs, Tricia Lin, Karyn O'Neil | 2023-07-18 |
| 11576986 | Macrocyclic chelators and methods of use thereof | Rhys Salter, Vadim Dudkin, Fengbin Song, Wei Zhang, John Andrew Keith | 2023-02-14 |
| 11311640 | Air sterilizer apparatus and method | — | 2022-04-26 |
| 11072663 | Cysteine engineered fibronectin type III domain binding molecules | Steven Jacobs, Tricia Lin, Karyn O'Neil | 2021-07-27 |
| 10844111 | Prostate specific membrane antigen binding fibronectin type III domains | Rosa Cardoso, Michael Diem, Linus Hyun, Steven Jacobs, Donna Klein +2 more | 2020-11-24 |
| 10844122 | Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof | Glenn Mark Anderson, Rosa Cardoso, Michael Diem, Francois Gaudet, Benjamin Harman +15 more | 2020-11-24 |
| 10662235 | Cysteine engineered fibronectin type III domain binding molecules | Mark Anderson, Ricardo Attar, Michael Diem, Linus Hyun, Alastair King +5 more | 2020-05-26 |
| 10196446 | Cysteine engineered fibronectin type III domain binding molecules | Steven Jacobs, Tricia Lin, Karyn O'Neil | 2019-02-05 |